The pros and cons of urinary lipoarabinomannan testing

AIDS

Volumn 26, Issue 17, 2012, Pages 2263-2264

  Boyles, Tom H ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOARABINOMANNAN;

DIAGNOSTIC VALUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PREDICTIVE VALUE; PRIORITY JOURNAL; TUBERCULOSIS; URINALYSIS; URINE LEVEL;

FEMALE; HIV SEROPOSITIVITY; HUMANS; LIPOPOLYSACCHARIDES; MALE; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TUBERCULOSIS;

EID: 84869420837     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283573286     Document Type: Letter

References (2)

1. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Clinical significance of lipoarabinomannan (LAM) detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis. AIDS 2012. [Epub ahead of print]
2. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIVassociated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 2012; 12:201-209.